Patents by Inventor Neelam Kumar

Neelam Kumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CELL DEATH BIOMARKER
    Publication number: 20240118266
    Abstract: The invention relates to cell death of cancer cells, and in particular to biomarkers that may be used to identify cancer cells that are sensitive to death receptor ligand (DRL)-induced cell death. The invention also extends to prognostic methods and kits for identifying cancer cells that are sensitive to DRL-induced cell death. The invention further extends to novel compositions and therapeutic methods using such compositions for treating cancer.
    Type: Application
    Filed: April 12, 2023
    Publication date: April 11, 2024
    Inventors: Samuel Janes, Krishna Kolluri, Ultan McDermott, Neelam Kumar
  • Cell death biomarker
    Patent number: 11789012
    Abstract: The invention relates to cell death of cancer cells, and in particular to biomarkers that may be used to identify cancer cells that are sensitive to death receptor ligand (DRL)-induced cell death. The invention also extends to prognostic methods and kits for identifying cancer cells that are sensitive to DRL-induced cell death. The invention further extends to novel compositions and therapeutic methods using such compositions for treating cancer.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: October 17, 2023
    Assignee: UCL Business Ltd
    Inventors: Samuel Janes, Krishna Kolluri, Ultan McDermott, Neelam Kumar
  • CELL DEATH BIOMARKER
    Publication number: 20190257818
    Abstract: The invention relates to cell death of cancer cells, and in particular to biomarkers that may be used to identify cancer cells that are sensitive to death receptor ligand (DRL)-induced cell death. The invention also extends to prognostic methods and kits for identifying cancer cells that are sensitive to DRL-induced cell death. The invention further extends to novel compositions and therapeutic methods using such compositions for treating cancer.
    Type: Application
    Filed: September 15, 2017
    Publication date: August 22, 2019
    Inventors: Samuel Janes, Krishna Kolluri, Ultan McDermott, Neelam Kumar